ImClone falls on BLA setback

IMCL was off $8.79 (16%) to $46.46 on Monday. On Friday after market close, the company said the FDA would not accept for filing its BLA for Erbitux (

Read the full 299 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE